Select Page

Malawi

The first Malawi Population-based HIV Impact Assessment (MPHIA) survey was conducted between November 2015-August 2016 to measure the status of Malawi’s HIV response.

MPHIA 2016 offered HIV counseling and testing with return of results. The survey team visited over 11,000 households to collect this information.

In January 2020, a second MPHIA survey was launched by the Ministry of Health to assess the country’s progress towards HIV epidemic control. MPHIA 2020 offered HIV counseling with return of results. The survey team visited over 12,000 households.

Summary sheet findings can be found below.

MPHIA 2020: Key Findings*

%

Annual HIV incidence among adults

%

HIV prevalence among adults

%

Viral load suppression among adults living with HIV*

MPHIA 2020: 95-95-95 among adults living with HIV

50%

Adults living with HIV who knew their HIV status

0%

Adults who were aware of their HIV status who were on ART

75%

Adults who were on ART who had viral load suppression

*MPHIA 2015-2016 Summary Sheet and Final Report, as well as related reports and publications, can be found below.

Related Resources

No results found.
Recent PHIA News
From Arm to Freezer: PHIA Project Laboratory Network Supports Ambitious HIV Testing Targets
From Arm to Freezer: PHIA Project Laboratory Network Supports Ambitious HIV Testing Targets
August 18, 2016
The Population-based HIV Impact Assessment (PHIA) Project, which relies on laboratory testing of blood samples as a core component, is providing answers to these questions. Led by ICAP at Columbia University, the PHIA surveys will assess the HIV epidemic in 13 select countries located primarily in sub-Saharan Africa. Fieldwork is nearly complete in three countries, with ten more national surveys to follow over the next two to three years.

This project is supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention under the terms of cooperative agreement #U2GGH001226. The contents of this site are the responsibility of ICAP and do not necessarily reflect the views of the United States Government.  The mark “CDC” is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

 

ICAP at Columbia University, 722 West 168th Street, New York, NY 10032
ICAP • CONTACT • PRIVACY POLICY